Evolv Technologies Holdings, Inc. filings document the public-company disclosures of an AI-based security screening business with Class A common stock and warrants listed on Nasdaq. Its Form 8-K reports include financial-results releases, Regulation FD disclosures, board and officer changes, stockholder meeting results, credit-agreement disclosures and registration-statement amendments tied to resale securities and warrant exercises.
Proxy materials describe director elections, executive compensation, auditor ratification, board committee matters and shareholder voting procedures. The filings also identify capital-structure elements, including Class A common stock, warrants and subsidiary borrowing arrangements, alongside governance and reporting matters for Evolv’s screening technology operations.
Evolv Technologies Holdings, Inc. announced a Board change, with long-time director and early venture investor Bilal Zuberi resigning to pursue other endeavors, with no disagreements cited with leadership or the Board.
The company appointed Henrik Kühl, age 46, to its Board of Directors effective February 12, 2026, as a Class III director through the 2027 annual meeting. He will also serve on the Audit Committee. The Board determined that Kühl is independent under Nasdaq and SEC rules and qualifies as an “audit committee financial expert.”
Kühl brings more than 25 years of experience in corporate strategy and development, including his current role as Senior Vice President, Strategy & Corporate Development at Axon. He will receive compensation as a non-employee director under Evolv’s Director Compensation Policy.
Evolv Technologies Holdings, Inc. director Michael Ellenbogen reported option exercises and share sales in Class A Common Stock. On January 16, 2026, he exercised a stock option for 80,745 shares at an exercise price of $0.24 per share and acquired the same number of shares. That same day, he sold 80,745 shares at a weighted average price of $6.20 per share, with individual sale prices ranging from $6.13 to $6.37, under a pre-existing Rule 10b5-1 trading plan entered into on June 12, 2025.
After these transactions, Ellenbogen directly beneficially owned 2,083,961 shares of Class A Common Stock and held 1,300,739 stock options. He also indirectly held 151,135 shares through the Family Horizon Trust.
Evolv Technologies Holdings, Inc. reported that director Mark J. Sullivan received a grant of 3,731 Restricted Stock Units (RSUs) on January 2, 2026. Each RSU represents a contingent right to receive one share of the company’s Class A common stock at no purchase price, and the RSUs have no expiration date.
The filing states that these 3,731 RSUs will vest in full on December 31, 2026, after which they can settle into an equal number of Class A common shares, assuming vesting conditions are met. Following this award, Sullivan beneficially owns 3,731 RSUs directly.
Evolv Technologies Holdings, Inc. (EVLV) reported a new equity grant to one of its directors. Director Michael Ellenbogen was awarded 3,731 Restricted Stock Units (RSUs) on January 2, 2026, at a price of $0 per unit, and now holds 3,731 derivative securities directly following this transaction.
Each RSU represents a contingent right to receive one share of Evolv’s Class A common stock and has no expiration date. According to the disclosure, all 3,731 RSUs will vest in full on December 31, 2026, meaning Ellenbogen will receive an equal number of Class A shares if the vesting conditions are satisfied.
Evolv Technologies Holdings, Inc. director Michael Ellenbogen reported insider transactions in Class A Common Stock. On December 15, 2025 he exercised stock options for 80,745 shares at an exercise price of $0.24 per share and on the same day sold 80,745 shares at a weighted average price of $6.91 per share under a Rule 10b5-1 trading plan entered into on June 12, 2025. The sales occurred in multiple trades at prices ranging from $6.75 to $7.20.
After these transactions he held 2,083,961 shares directly, 151,135 shares indirectly through the Family Horizon Trust, and 1,381,484 stock options.
Evolv Technologies Holdings, Inc. (EVLV) executive Robert Marshall, the company’s Chief Revenue Officer, reported an open-market purchase of Class A common stock. On 11/25/2025, he acquired 7,000 shares at a price of $6.06 per share, reported with transaction code "P" for a purchase. Following this transaction, he beneficially owns 7,000 Class A shares, held directly.
Evolv Technologies Holdings, Inc. (EVLV) reported an insider share purchase by its President & CEO and Director, John Kedzierski. On 11/21/2025, the reporting person bought 8,000 shares of Class A common stock in an open market transaction at a weighted average price of $5.91 per share. The filing notes the shares were acquired in multiple trades at prices ranging from $5.89 to $5.91, and the reporting person has offered to provide full trade details upon request. After this transaction, the insider directly holds 8,000 shares.
Evolv Technologies Holdings, Inc. (EVLV) reported an insider share purchase by a director. On 11/21/2025, the reporting person acquired 15,000 shares of Class A common stock in an open market purchase at a price of $5.6797 per share, through an IRA account. Following this transaction, the director beneficially owns 44,081 shares indirectly through the IRA and 331,960 shares directly. The filing is made by a single reporting person in the capacity of director, highlighting continued personal equity ownership in the company.
Evolv Technologies Holdings, Inc. (EVLV) director Richard Shapiro reported multiple open-market purchases of Class A common stock on 11/20/2025. He bought 30,000 shares directly at a weighted average price of about $6.00, with individual trades ranging from $5.97 to $6.02. He also acquired 7,500 shares held by a trust over which he has voting and dispositive power and 8,800 shares held by his spouse in a retirement plan, both at weighted average prices around $6.02. After these transactions, he directly owned 52,515 shares, while indirect holdings included shares in the trust and accounts related to his spouse.
Evolv Technologies Holdings, Inc. (EVLV) director reported an option exercise and share sale. On 11/17/2025, the reporting person exercised stock options to acquire 80,745 shares of Class A common stock at $0.24 per share and then sold 80,745 shares at a weighted average price of $5.8, with individual trades ranging from $5.69 to $5.99. These transactions were made under a Rule 10b5-1 trading plan entered into on June 12, 2025. After the transactions, the reporting person directly beneficially owned 2,083,961 shares, with an additional 151,135 shares held indirectly through the Family Horizon Trust, and continued to hold 1,462,229 stock options.